QS Investors’s Evolent Health EVH Stock Holding History

QS Investors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-89	Closed	-$2K	–	1707
2018 Q4	$2K	Hold	89	–	–	﹤0.01%	1642
2018 Q3	$3K	Hold	89	–	–	﹤0.01%	1639
2018 Q2	$2K	Hold	89	–	–	﹤0.01%	1680
2018 Q1	$1K	Hold	89	–	–	﹤0.01%	1761
2017 Q4	$1K	Hold	89	–	–	﹤0.01%	1769
2017 Q3	$2K	Buy	89 +39	+78%	+$804	﹤0.01%	1659
2017 Q2	$1K	Hold	50	–	–	﹤0.01%	1741
2017 Q1	$1K	Buy	50 +28	+127%	+$537	﹤0.01%	1761
2016 Q4	$1K	Hold	22	–	–	﹤0.01%	1586
2016 Q3	$1K	Hold	22	–	–	﹤0.01%	1571
2016 Q2	$1K	Buy	+22	New	+$302	﹤0.01%	1603
2016 Q1	–	Sell	-23	Closed	-$1K	–	2005
2015 Q4	$1K	Buy	+23	New	+$339	﹤0.01%	1619

Other funds holding EVH

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

QS Investors's EVH Position: Q1 2019 in Review

QS Investors sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 89 shares — an estimated $2K sold.

QS Investors first reported a position in EVH in Q4 2015 and held it in 12 quarters. The position peaked at $3K in Q3 2018. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

QS Investors reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
QS Investors sold 89 Evolent Health shares in Q1 2019, an estimated $2K.
QS Investors first reported a position in Evolent Health in Q4 2015 and held it in 12 quarters.
QS Investors's Evolent Health position peaked at $3K in Q3 2018.
192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on QS Investors's 13F filing for Q1 2019, filed 15 May 2019.